Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention

Nobuhiro Nakanishi,Koichi Kaikita,Masanobu Ishii,Naoto Kuyama,Noriaki Tabata,Miwa Ito,Kenshi Yamanaga,Koichiro Fujisue,Tadashi Hoshiyama,Hisanori Kanazawa,Shinsuke Hanatani,Daisuke Sueta,Seiji Takashio,Yuichiro Arima,Satoshi Araki,Hiroki Usuku,Taishi Nakamura,Eiichiro Yamamoto,Hirofumi Soejima,Kenichi Matsushita,Kenichi Tsujita
DOI: https://doi.org/10.1007/s12928-023-00920-3
2023-03-08
Cardiovascular Intervention and Therapeutics
Abstract:Although the Japanese high bleeding risk criteria (J-HBR) were established to predict bleeding risk in patients undergoing percutaneous coronary intervention (PCI), the thrombogenicity in the J-HBR status remains unknown. Here, we examined the relationships among J-HBR status, thrombogenicity and bleeding events. This study was a retrospective analysis of 300 consecutive patients who underwent PCI. Blood samples obtained on the day of PCI were used in the total thrombus-formation analysis system (T-TAS) to investigate the thrombus-formation area under the curve (AUC; PL 18 -AUC 10 for platelet chip; AR 10 -AUC 30 for atheroma chip). The J-HBR score was calculated by adding 1 point for any major criterion and 0.5 point for any minor criterion. We assigned patients to three groups based on J-HBR status: a J-HBR-negative group ( n = 80), a low score J-HBR-positive group (positive/low, n = 109), and a high score J-HBR-positive group (positive/high, n = 111). The primary end point was the 1-year incidence of bleeding events defined by the Bleeding Academic Research Consortium types 2, 3, or 5. Both PL 18 -AUC 10 and AR 10 -AUC 30 levels were lower in the J-HBR-positive/high group than the negative group. Kaplan–Meier analysis showed worse 1-year bleeding event-free survival in the J-HBR-positive/high group compared with the negative group. In addition, both T-TAS levels in J-HBR positivity were lower in those with bleeding events than in those without bleeding events. In multivariate Cox regression analyses, the J-HBR-positive/high status was significantly associated with 1-year bleeding events. In conclusion, the J-HBR-positive/high status could reflect low thrombogenicity as measured by T-TAS and high bleeding risk in patients undergoing PCI.
What problem does this paper attempt to address?